News
Veozah (fezolinetant) was approved in 2023 by the FDA to treat moderate to severe hot flashes. A similar drug, elinzanetant, ...
Research suggests women with high breast cancer risk and menopausal symptoms could benefit from Duavee, which reduced breast ...
There may be relief for women who suffer through hot flashes, night sweats, chills and other symptoms of menopause. The Food and Drug Administration approved Veozah (generic name: fezolinetant ...
Hosted on MSN9mon
Hot flash drug shows significant benefits in clinical trialsThe investigational drug elinzanetant significantly reduces the frequency and severity of hot flashes associated with menopause while improving women's quality of life, according to new UVA Health ...
Veozah, a nonhormonal drug, is effective against a signature symptom of menopause. By Alisha Haridasani Gupta The Food and Drug Administration approved a new nonhormonal oral drug Friday, under ...
The Food and Drug Administration announced Friday it has approved a new kind of drug to treat moderate to severe hot flashes caused by menopause, which could offer relief to millions of women who ...
a non-hormonal oral drug that can treat moderate to severe hot flashes, is a big deal, Dr. Mason says. “It’s great to have an option that’s non-hormonal” for people who can’t start—or ...
A new treatment for hot flashes brought relief and a better night’s rest for women experiencing these disruptive symptoms during menopause. Two phase 3 clinical trials compared the drug ...
More hopeful news on the menopause front: Bayer announced on Monday encouraging results in two Phase 3 trials for its non-hormonal drug candidate, elinzanetant, meant to treat hot flashes.
Often women suffer with hot flashes and do not seek help. But there are several treatment options available that work to reduce hot flashes, including a newly FDA approved treatment Veozah ...
Women have long searched for remedies for the bothersome hot flashes that often come with menopause. In a novel investigation, researchers at UC San Francisco tested the benefits of continuously ...
U.S. health regulators on Friday approved a new type of drug for women dealing with uncomfortable hot flashes caused by menopause.The Food and Drug Administration approved the once-a-day pill from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results